AirLife

AirLife

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $13M

Overview

AirLife is a rapidly growing, private medical device company specializing in anesthesia and respiratory consumables. Through strategic acquisitions and product development, it has built a broad portfolio of branded products used across acute care, EMS, surgery centers, and home care settings. The company demonstrates a focus on innovation, operational expansion, and ESG principles, positioning itself as a key supplier in the respiratory and critical care markets.

RespiratoryCritical CareAnesthesia

Technology Platform

Medical device manufacturer and distributor with a portfolio of branded consumable products for airway management, respiratory therapy, anesthesia, and patient monitoring. Focus on product design, materials, and system integration.

Funding History

2
Total raised:$13M
Series A$10M
Seed$3M

Opportunities

Significant growth in the home respiratory care market and the ongoing demand for disposable medical consumables in hospitals and surgery centers provide a stable, recurring revenue base.
Strategic acquisitions and partnerships offer a clear path to expand product portfolios and geographic reach.

Risk Factors

Intense competition from large, established medtech companies and pricing pressure from hospital Group Purchasing Organizations (GPOs).
Integration challenges and operational risks associated with rapid growth through acquisitions.
Dependence on complex global supply chains for raw materials.

Competitive Landscape

AirLife competes in the crowded respiratory and anesthesia consumables market against giants like Medtronic, Philips, Fisher & Paykel, and Vyaire, as well as numerous specialized players. Its strategy is to compete through a broad, integrated product portfolio, strategic distribution, and a focus on customer-specific solutions across care settings.